tetano
Editor, Senior Moderator
Sci Rep
. 2022 Dec 15;12(1):21694.
doi: 10.1038/s41598-022-26135-9.
A potential role for SARS-CoV-2 small viral RNAs in targeting host microRNAs and modulating gene expression
Zachary T Neeb[SUP] #[/SUP][SUP] 1 [/SUP], Alexander J Ritter[SUP] #[/SUP][SUP] 2 [/SUP], Lokendra V Chauhan[SUP] 3 [/SUP], Sol Katzman[SUP] 4 [/SUP], W Ian Lipkin[SUP] 3 [/SUP], Nischay Mishra[SUP] 5 [/SUP], Jeremy R Sanford[SUP] 6 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease (COVID-19) in humans, with symptoms ranging from mild to severe, including fatality. The molecular mechanisms surrounding the effects of viral infection on the host RNA machinery remain poorly characterized. We used a comparative transcriptomics approach to investigate the effects of SARS-CoV-2 infection on the host mRNA and sRNA expression machinery in a human lung epithelial cell line (Calu-3) and an African green monkey kidney cell line (Vero-E6). Upon infection, we observed global changes in host gene expression and differential expression of dozens of host miRNAs, many with known links to viral infection and immune response. Additionally, we discovered an expanded landscape of more than a hundred SARS-CoV-2-derived small viral RNAs (svRNAs) predicted to interact with differentially expressed host mRNAs and miRNAs. svRNAs are derived from distinct regions of the viral genome and sequence signatures suggest they are produced by a non-canonical biogenesis pathway. 52 of the 67 svRNAs identified in Calu-3 cells are predicted to interact with differentially expressed miRNAs, with many svRNAs having multiple targets. Accordingly, we speculate that these svRNAs may play a role in SARS-CoV-2 propagation by modulating post-transcriptional gene regulation, and that methods for antagonizing them may have therapeutic value.
. 2022 Dec 15;12(1):21694.
doi: 10.1038/s41598-022-26135-9.
A potential role for SARS-CoV-2 small viral RNAs in targeting host microRNAs and modulating gene expression
Zachary T Neeb[SUP] #[/SUP][SUP] 1 [/SUP], Alexander J Ritter[SUP] #[/SUP][SUP] 2 [/SUP], Lokendra V Chauhan[SUP] 3 [/SUP], Sol Katzman[SUP] 4 [/SUP], W Ian Lipkin[SUP] 3 [/SUP], Nischay Mishra[SUP] 5 [/SUP], Jeremy R Sanford[SUP] 6 [/SUP]
Affiliations
- PMID: 36522444
- DOI: 10.1038/s41598-022-26135-9
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease (COVID-19) in humans, with symptoms ranging from mild to severe, including fatality. The molecular mechanisms surrounding the effects of viral infection on the host RNA machinery remain poorly characterized. We used a comparative transcriptomics approach to investigate the effects of SARS-CoV-2 infection on the host mRNA and sRNA expression machinery in a human lung epithelial cell line (Calu-3) and an African green monkey kidney cell line (Vero-E6). Upon infection, we observed global changes in host gene expression and differential expression of dozens of host miRNAs, many with known links to viral infection and immune response. Additionally, we discovered an expanded landscape of more than a hundred SARS-CoV-2-derived small viral RNAs (svRNAs) predicted to interact with differentially expressed host mRNAs and miRNAs. svRNAs are derived from distinct regions of the viral genome and sequence signatures suggest they are produced by a non-canonical biogenesis pathway. 52 of the 67 svRNAs identified in Calu-3 cells are predicted to interact with differentially expressed miRNAs, with many svRNAs having multiple targets. Accordingly, we speculate that these svRNAs may play a role in SARS-CoV-2 propagation by modulating post-transcriptional gene regulation, and that methods for antagonizing them may have therapeutic value.